Evidence map›Paper›PMID 34416206›Full record

ArticleThe Lancet. Global health2021

Validating novel diagnostic assays for tuberculosis in the context of existing tools.

Andrew D Kerkhoff, Adithya Cattamanchi, Monde Muyoyeta, Claudia M Denkinger, David W Dowdy

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Andrew D KerkhoffDivision of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA 94110, USA. Electronic address: andrew.kerkhoff@ucsf.edu.
Adithya CattamanchiCenter for Tuberculosis and Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA 94110, USA; Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda.
Monde MuyoyetaTB Department, Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Claudia M DenkingerDivision of Tropical Medicine, Center of Infectious Diseases, University of Heidelberg, Heidelberg, Germany.
David W DowdyUganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Feasibility and acceptability of a peer-led strategy to improve community tuberculosis case finding among non-household contacts in ZambiaK23AI157914 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KERKHOFF, ANDREW · 2021 to 2025
$999k
NIAID NIH HHS K23 AI157914
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosisHumans

Identifiers

PMID34416206
PMCPMC9541186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.